GO:0017005 3'-tyrosyl-DNA phosphodiesterase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0017005 describes the enzymatic activity that hydrolyzes 3'-phosphotyrosyl groups formed as covalent intermediates between DNA topoisomerase I and DNA during backbone breakage.
• This activity is essential for removing topoisomerase I-DNA adducts and maintaining genomic stability.
• The enzyme can be detected in situ using activity gels, providing a direct readout of its function in DNA repair.
• Defects in 3'-tyrosyl-DNA phosphodiesterase activity are linked to cancer and neurodegenerative disorders.
• Studying this activity requires specialized assays such as radioactive phosphodiesterase assays and activity gel electrophoresis.
• CRISPR-based models (knockout, knock-in, overexpression) enable causal interrogation of genes encoding this activity.
Description
3'-tyrosyl-DNA phosphodiesterase activity (GO:0017005) is a molecular function that catalyzes the hydrolysis of 3'-phosphotyrosyl groups formed as covalent intermediates between DNA topoisomerase I and DNA during DNA backbone breakage. This activity is critical for resolving topoisomerase I-DNA adducts, which if left unrepaired can lead to DNA double-strand breaks and cell death. Researchers study this activity to understand DNA repair mechanisms and to develop therapeutic strategies for cancer and other diseases. The enzyme responsible for this activity can be detected using in situ activity gels, allowing direct visualization of its function in cellular contexts. Given its role in maintaining genomic integrity, 3'-tyrosyl-DNA phosphodiesterase activity is a promising target for drug discovery and a key focus in molecular biology.
3'-tyrosyl-DNA phosphodiesterase activity At A Glance
| GO ID | GO:0017005 |
|---|---|
| GO term | 3'-tyrosyl-DNA phosphodiesterase activity |
| Ontology | molecular_function |
| Synonym | (none) |
| Major function | Hydrolysis of 3'-phosphotyrosyl groups formed as covalent intermediates between DNA topoisomerase I and DNA |
| Definition source | QuickGO |
| Related process | DNA repair, DNA backbone breakage resolution |
| Substrate | 3'-phosphotyrosyl-DNA intermediate |
| Product | DNA with free 3'-phosphate or 3'-hydroxyl and free tyrosine |
What Is GO:0017005?
According to the Gene Ontology, GO:0017005 (3'-tyrosyl-DNA phosphodiesterase activity) is defined as the catalysis of the hydrolysis of 3'-phosphotyrosyl groups formed as covalent intermediates (in DNA backbone breakage) between DNA topoisomerase I and DNA. In simpler terms, it is an enzymatic activity that cleaves the chemical bond between a tyrosine residue and a phosphate group at the 3' end of DNA, specifically when topoisomerase I is trapped on the DNA. This process is essential for removing the enzyme-DNA adduct and restoring the DNA backbone for repair.
Why Is 3'-tyrosyl-DNA phosphodiesterase activity Important in Cell Biology?
3'-tyrosyl-DNA phosphodiesterase activity is crucial for maintaining genomic stability because it removes topoisomerase I-DNA covalent adducts that can block DNA replication and transcription, leading to double-strand breaks and cell death if unresolved. This activity is also important for the efficacy of topoisomerase I inhibitors, a class of anticancer drugs, as it can modulate cellular sensitivity to these agents. Understanding this activity provides insights into DNA repair pathways and potential therapeutic targets for cancer and neurodegenerative diseases.
• Maintains genomic integrity by resolving topoisomerase I-DNA adducts.
• Prevents DNA double-strand breaks and cell death caused by trapped topoisomerase I.
• Modulates sensitivity to topoisomerase I inhibitors used in cancer therapy.
• Plays a role in DNA repair pathways and cellular stress responses.
• Its dysfunction is associated with cancer and neurodegenerative disorders.
• Can be targeted for drug discovery to enhance chemotherapy efficacy.
• Detectable via in situ activity gels for direct functional analysis.
• Requires specialized assays for accurate measurement.
What Happens During 3'-tyrosyl-DNA phosphodiesterase activity?
Formation of the Topoisomerase I-DNA Covalent Intermediate
In simple terms: Topoisomerase I gets stuck on DNA after cutting it.
During DNA relaxation, topoisomerase I forms a covalent intermediate with the 3' end of the broken DNA strand via a phosphotyrosyl bond. This intermediate is normally transient, but can become trapped by DNA damage or topoisomerase I inhibitors. The trapped complex is a substrate for 3'-tyrosyl-DNA phosphodiesterase activity.
Recognition and Hydrolysis of the 3'-Phosphotyrosyl Bond
In simple terms: The enzyme cuts the bond between the DNA and the stuck topoisomerase.
3'-tyrosyl-DNA phosphodiesterase activity catalyzes the hydrolysis of the 3'-phosphotyrosyl bond, freeing the DNA 3' end from topoisomerase I. This reaction restores the DNA backbone and allows repair to proceed. The activity is specific for the 3'-phosphotyrosyl linkage.
Release of Topoisomerase I and DNA End Processing
In simple terms: The topoisomerase is released, and the DNA end is cleaned up.
After hydrolysis, topoisomerase I is released from the DNA, and the DNA end is left with a 3'-phosphate or 3'-hydroxyl group. Further processing by other DNA repair enzymes may be required to restore the original DNA sequence. This step is critical for preventing persistent DNA damage.
Detection via In Situ Activity Gel
In simple terms: Scientists can see this activity directly in a gel assay.
An in situ activity gel for DNA repair 3'-phosphodiesterase allows visualization of enzymatic activity after gel electrophoresis. This method provides a direct functional readout and can be used to study the enzyme in various biological samples.
Key Genes Involved in GO:0017005 3'-tyrosyl-DNA phosphodiesterase activity
The following genes and proteins are directly or indirectly involved in 3'-tyrosyl-DNA phosphodiesterase activity and related DNA repair processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TDP1 | Encodes the enzyme responsible for 3'-tyrosyl-DNA phosphodiesterase activity | Central to resolving topoisomerase I-DNA adducts; mutations linked to cancer and neurodegeneration |
| TOP1 | DNA topoisomerase I, forms the covalent intermediate | Target of anticancer drugs; its trapping creates the substrate for TDP1 |
| TDP2 | 5'-tyrosyl-DNA phosphodiesterase, resolves 5'-adducts | Complementary activity for topoisomerase II-DNA adducts |
| PARP1 | Poly(ADP-ribose) polymerase, involved in DNA repair | Modulates repair pathways that may interact with TDP1 |
| XRCC1 | Scaffold protein in base excision repair | Potential functional interaction with TDP1 in repair |
| LIG3 | DNA ligase III, involved in repair | May process DNA ends after TDP1 action |
| ATM | DNA damage response kinase | Coordinates repair and cell cycle checkpoints |
| ATR | DNA damage response kinase | Responds to replication stress caused by topoisomerase I adducts |
| BRCA1 | Homologous recombination repair | May influence sensitivity to topoisomerase I inhibitors |
| BRCA2 | Homologous recombination repair | Interacts with repair pathways involving TDP1 |
| TP53 | Tumor suppressor, regulates DNA damage response | Mutations affect cellular response to topoisomerase I damage |
| POLB | DNA polymerase beta, gap filling | May process DNA ends after TDP1-mediated cleavage |
| FEN1 | Flap endonuclease, DNA repair | Potential role in processing repair intermediates |
| PCNA | Proliferating cell nuclear antigen, processivity factor | Involved in DNA replication and repair |
| RAD51 | Homologous recombination | Repairs double-strand breaks arising from unresolved adducts |
| MRE11 | Mre11 complex, DNA end processing | Processes DNA ends in repair |
| NBN | Nibrin, Mre11 complex | DNA damage response |
| RAD50 | Mre11 complex | DNA repair |
How Is 3'-tyrosyl-DNA phosphodiesterase activity Regulated?
The activity of 3'-tyrosyl-DNA phosphodiesterase is regulated at multiple levels, including post-translational modifications and protein-protein interactions. For example, phosphorylation of TDP1 by ATM/ATR kinases in response to DNA damage can modulate its activity and recruitment to damage sites. Additionally, the expression of TDP1 can be induced by cellular stress, and its activity may be influenced by interaction with other repair proteins such as PARP1 and XRCC1. However, detailed regulatory mechanisms remain an active area of research.
3'-tyrosyl-DNA phosphodiesterase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TDP1 | Spinocerebellar ataxia with axonal neuropathy (SCAN1) | Knockout or point-mutation knock-in in neuronal cell lines or iPSCs |
| TDP1 | Cancer chemoresistance | Overexpression or knockout in cancer cell lines treated with topoisomerase I inhibitors |
| TOP1 | Cancer, sensitivity to topoisomerase I inhibitors | Knockout or point mutations in cancer cell lines |
| ATM | Ataxia-telangiectasia, cancer predisposition | Knockout or point mutations in cell lines |
| BRCA1/2 | Hereditary breast and ovarian cancer | Knockout or knock-in in cell lines |
Cancer
Defects in 3'-tyrosyl-DNA phosphodiesterase activity can lead to genomic instability and cancer predisposition. Overexpression of TDP1 has been associated with resistance to topoisomerase I inhibitors, such as camptothecin and its derivatives, in cancer cells. Therefore, inhibiting TDP1 activity is a potential strategy to sensitize tumors to these chemotherapeutic agents.
Neurodegenerative Disorders
Mutations in TDP1 cause spinocerebellar ataxia with axonal neuropathy (SCAN1), a rare neurodegenerative disorder characterized by progressive cerebellar atrophy and peripheral neuropathy. This highlights the critical role of 3'-tyrosyl-DNA phosphodiesterase activity in maintaining neuronal health, likely due to the high demand for DNA repair in post-mitotic neurons.
Other Diseases
Altered TDP1 activity has also been implicated in other conditions, including viral infections and immune disorders, though the exact mechanisms are still being elucidated. Further research is needed to fully understand the disease associations.
From 3'-tyrosyl-DNA phosphodiesterase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TDP1 increase sensitivity to topoisomerase I inhibitors? | TDP1 knockout cell lines |
| Does a specific TDP1 mutation affect its catalytic activity? | Point-mutation knock-in of TDP1 |
| Can TDP1 be tagged for live-cell imaging? | Knock-in of fluorescent protein tag at endogenous TDP1 locus |
| Does overexpression of TDP1 confer chemoresistance? | TDP1 overexpression cell lines |
| What is the role of TDP1 in neuronal survival? | TDP1 knockout in iPSC-derived neurons |
| Can CRISPR screening identify synthetic lethal partners of TDP1? | Genome-wide CRISPR knockout library screening in TDP1-deficient cells |
How to Study the 3'-tyrosyl-DNA phosphodiesterase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In situ activity gel | Enzymatic activity of 3'-phosphodiesterase | Detection in cell lysates |
| Radioactive phosphodiesterase assay | Phosphodiesterase activity via radioactive substrate | Quantitative activity measurement |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identifying modifiers of drug sensitivity |
| Western blot | Protein expression levels | Validation of knockout/overexpression |
| Immunofluorescence | Protein localization and recruitment | Studying DNA damage foci |
| Comet assay | DNA breaks | Assessing genomic instability |
| Cell viability assay | Cellular sensitivity to drugs | Testing chemosensitivity |
| Next-generation sequencing | Mutations and gene expression | Genomic profiling |
In Situ Activity Gel
The in situ activity gel for DNA repair 3'-phosphodiesterase allows direct detection of enzymatic activity after gel electrophoresis. This method is useful for assessing TDP1 activity in cell lysates and tissues.
Radioactive Phosphodiesterase Assay
A radioactive assay can measure phosphodiesterase activity by monitoring the release of radioactive products from labeled substrates. This method provides high sensitivity and can be adapted for high-throughput screening.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate sensitivity to topoisomerase I inhibitors or that interact with TDP1. These screens are powerful for discovering synthetic lethal interactions.
Western Blot and Immunofluorescence
Western blotting and immunofluorescence can detect TDP1 protein levels and localization in cells. These methods are useful for validating knockout or overexpression models.
How CRISPR Can Be Used to Study GO:0017005 3'-tyrosyl-DNA phosphodiesterase activity
Knockout
CRISPR knockout of TDP1 can be used to study the consequences of loss of 3'-tyrosyl-DNA phosphodiesterase activity on DNA repair, drug sensitivity, and genomic stability. Knockout cell lines are valuable for identifying synthetic lethal interactions and validating drug targets.
Point Mutation
Introducing specific point mutations in TDP1 via CRISPR can help dissect the catalytic mechanism and identify residues critical for 3'-tyrosyl-DNA phosphodiesterase activity. Such models can also mimic disease-associated mutations like those found in SCAN1.
Knock-in
Knock-in of tags (e.g., GFP, HA) at the endogenous TDP1 locus allows real-time imaging and biochemical purification of the enzyme. This approach preserves endogenous regulation and provides insights into protein dynamics.
Overexpression
CRISPR activation or lentiviral overexpression of TDP1 can model chemoresistance and study the effects of elevated 3'-tyrosyl-DNA phosphodiesterase activity on cellular responses to topoisomerase I inhibitors. Overexpression models are useful for drug screening.
How EDITGENE Supports 3'-tyrosyl-DNA phosphodiesterase activity Research
Researchers studying 3'-tyrosyl-DNA phosphodiesterase activity-related genes often need to determine whether a candidate gene is causally involved in DNA repair, drug sensitivity, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for 3'-tyrosyl-DNA phosphodiesterase activity research.
Frequently Asked Questions About 3'-tyrosyl-DNA phosphodiesterase activity
What is 3'-tyrosyl-DNA phosphodiesterase activity?
It is an enzymatic activity (GO:0017005) that hydrolyzes 3'-phosphotyrosyl groups formed as covalent intermediates between DNA topoisomerase I and DNA during backbone breakage.
What genes are involved in 3'-tyrosyl-DNA phosphodiesterase activity?
The primary gene is TDP1, which encodes the enzyme responsible for this activity. Other genes such as TOP1, TDP2, PARP1, and XRCC1 are also involved in related DNA repair pathways.
How is 3'-tyrosyl-DNA phosphodiesterase activity measured?
It can be measured using in situ activity gels or radioactive phosphodiesterase assays.
What diseases are associated with defects in this activity?
Defects in TDP1 cause spinocerebellar ataxia with axonal neuropathy (SCAN1), and altered activity is linked to cancer chemoresistance.
Why is 3'-tyrosyl-DNA phosphodiesterase activity important for cancer treatment?
It modulates sensitivity to topoisomerase I inhibitors, and inhibiting it can sensitize cancer cells to these drugs.
Can CRISPR be used to study 3'-tyrosyl-DNA phosphodiesterase activity?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to study the function of TDP1 and related genes.
What is the substrate of 3'-tyrosyl-DNA phosphodiesterase?
The substrate is the 3'-phosphotyrosyl-DNA intermediate formed by topoisomerase I.
How does 3'-tyrosyl-DNA phosphodiesterase activity relate to DNA repair?
It removes topoisomerase I-DNA adducts, allowing DNA repair pathways to restore the DNA backbone.
Are there inhibitors of 3'-tyrosyl-DNA phosphodiesterase?
Yes, several small molecule inhibitors are being developed as potential anticancer agents, though none are yet approved for clinical use.
What model systems are used to study 3'-tyrosyl-DNA phosphodiesterase activity?
Common models include knockout cell lines, point-mutation knock-ins, and overexpression systems, often generated using CRISPR technology.
Conclusion
3'-tyrosyl-DNA phosphodiesterase activity (GO:0017005) is a critical enzymatic function for resolving topoisomerase I-DNA adducts and maintaining genomic stability. Its role in cancer chemoresistance and neurodegenerative disease makes it an attractive target for therapeutic development. Advances in CRISPR-based models and screening technologies are accelerating research into this activity and its associated genes. Continued investigation will likely uncover new insights into DNA repair mechanisms and disease treatments.
References
- 1. Sander M. 1997. In situ activity gel for DNA repair 3'-phosphodiesterase.. Nucleic Acids Res 25(9):1868-9 PMID: 9108175
- 4. Kazmierczak BI. 2017. Determining Phosphodiesterase Activity (Radioactive Assay).. Methods Mol Biol 1657:279-283 PMID: 28889301
